Gujarat Inject (Kerala) Limited (BOM:524238)
India · Delayed Price · Currency is INR 9.18
-0.22 (-2.34%)
At close: Oct 1, 2026
Gujarat Inject (Kerala) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 6.78 | 0.26 | 29.19 | 0.62 | 0.08 |
Cash & Short-Term Investments | 6.78 | 6.78 | 0.26 | 29.19 | 0.62 | 0.08 |
Cash Growth | 2478.71% | 2478.71% | -99.10% | 4633.05% | 721.31% | -11.65% |
Accounts Receivable | - | 63.47 | 71.8 | 29.77 | - | - |
Receivables | - | 69.38 | 91.35 | 57.66 | - | - |
Inventory | - | 39.47 | - | - | - | 0.09 |
Other Current Assets | - | 0 | - | - | 0.09 | 0.08 |
Total Current Assets | - | 115.63 | 91.61 | 86.85 | 0.7 | 0.24 |
Property, Plant & Equipment | - | 207.65 | - | - | - | - |
Long-Term Investments | - | - | - | - | - | 0.02 |
Long-Term Accounts Receivable | - | - | - | - | 2.33 | 0.39 |
Other Long-Term Assets | - | 0.05 | - | - | - | - |
Total Assets | - | 366.65 | 119.51 | 86.85 | 3.03 | 0.65 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 202.46 | 16.71 | 1.1 | 3.23 | - |
Accrued Expenses | - | 0.87 | 0.17 | 0.3 | 2.1 | - |
Short-Term Debt | - | - | - | - | 1.93 | 4.15 |
Current Income Taxes Payable | - | 6.21 | 2.49 | - | - | - |
Other Current Liabilities | - | 38.82 | 0.03 | - | - | - |
Total Current Liabilities | - | 248.35 | 19.38 | 1.4 | 7.25 | 4.15 |
Long-Term Debt | - | - | - | - | 4.15 | 48.85 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | -57.63 |
Other Long-Term Liabilities | - | - | - | - | - | 14.09 |
Total Liabilities | - | 248.35 | 19.38 | 1.4 | 11.41 | 9.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 146.35 | 146.35 | 112.92 | 48.85 | 48.85 |
Additional Paid-In Capital | - | 34.08 | 34.08 | - | 34.08 | 34.08 |
Retained Earnings | - | -62.13 | -80.3 | - | -91.3 | -91.73 |
Comprehensive Income & Other | - | - | - | -27.47 | - | - |
Shareholders' Equity | 118.3 | 118.3 | 100.12 | 85.45 | -8.37 | -8.81 |
Total Liabilities & Equity | - | 366.65 | 119.51 | 86.85 | 3.03 | 0.65 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | - | - | 6.08 | 53 |
Net Cash (Debt) | 6.78 | 6.78 | 0.26 | 29.19 | -5.46 | -52.92 |
Net Cash Growth | 2478.71% | 2478.71% | -99.10% | - | - | - |
Net Cash Per Share | 0.05 | 0.05 | 0.00 | 0.32 | -0.11 | -1.08 |
Filing Date Shares Outstanding | 145.53 | 146.49 | 146.35 | 113.07 | 48.99 | 48.99 |
Total Common Shares Outstanding | 145.53 | 146.49 | 146.35 | 113.07 | 48.99 | 48.99 |
Working Capital | - | -132.72 | 72.23 | 85.45 | -6.55 | -3.91 |
Book Value Per Share | 0.81 | 0.81 | 0.68 | 0.76 | -0.17 | -0.18 |
Tangible Book Value | 118.3 | 118.3 | 100.12 | 85.45 | -8.37 | -8.81 |
Tangible Book Value Per Share | 0.81 | 0.81 | 0.68 | 0.76 | -0.17 | -0.18 |